NCT00015106View on ClinicalTrials.gov

Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

November 30, 1997

Primary Completion Date

January 31, 1999

Study Completion Date

February 28, 1999

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Lamotrigine

Trial Locations (1)

45220

Cincinnati MDRU, Cincinnati

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015106 - Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7 | Biotech Hunter | Biotech Hunter